All Regulatory Rapporteur articles in February 2026
View all stories from this issue.
-
EditorialMedTech in transition: Regulation, risk and real-world impact
This issue is shaped by a unifying theme: how risk, evidence, inclusivity and innovation are being brought to the forefront by evolving regulatory expectations across the medical device lifecycle.
-
ContentsRegulatory Rapporteur February 2026 – Contents
The February issue of Regulatory Rapporteur focuses on MedTech.
-
JournalNavigating regulatory scrutiny: An analysis of requests for information in EU combined clinical trials
This article explores aspects of IVDR and how to implement these during clinical trial processes including submissions.
-
JournalParenteral drug delivery systems: Driving clinical success
This article examines the key challenges and best practices in developing parenteral drug delivery systems that pair drugs with specialised devices.
-
JournalReckoning with risk: Navigating MedTech innovation
This article discusses different risks within MedTech and how these can be leveraged for innovation and progress.
-
JournalWearable technology: The fine regulatory line between health and wellness
This article analyses the distinction between medical devices and ‘lifestyle’ technologies and the regulatory, commercial and ethical considerations created by this form of market positioning.
-
JournalFrom design to diversity: Embedding women’s health into medical device innovation and regulation
This article analyses how to integrate women’s health considerations to ensure inclusivity throughout the medical device development lifecycle.